curriculum was developed for nurses. SBML is an educational model that engages learners in simulated scenarios and involves deliberate practice until a predetermined standard is achieved. The SBML curriculum consisted of a pre-training skills assessment, watching a recorded lecture and demonstrational video, deliberate practice on a simulator with expert feedback, and a post-training skills assessment. Nurses then completed 5 successful proctored insertions on patients before becoming independent. There was no formal USGIV training for physicians. We extracted data from the electronic medical record on all ED visits where IV access was attempted from January 2015 -December 2017. Patient visits were categorized as standard of care (SOC) patients or DIVA patients. We defined SOC patients as those who received an IV in 2 attempts, while DIVA patients received an IV in 3 attempts or required an USGIV. We measured clinical outcomes including time to IV placement, time to lab results, time to IV pain medication, and ED length of stay (LOS) between SOC patient and DIVA patients. We also compared these outcomes as well as the number of insertion attempts between MD and RN for visits where an USGIV was inserted.
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Results: Over the study period, 148,559 ED visits were included. DIVA occurred in 8.9% of patient visits. DIVA resulted in significant delays when compared to SOC patients, including increased time to IV placement (120.9 versus 65.8 min; p<0.01), increased time to laboratory results (118.2 versus 81.1 min, p<0.01), increased time to IV pain medication (192.7 Conclusions: To our knowledge, this is the largest study exploring how DIVA affects care deliver and delays in the ED. Our study shows that DIVA is a prevalent condition, and leads to delays in IV access, time to diagnostic and therapeutic interventions, and increased LOS. While USGIV is known to be effective in obtaining access in DIVA patients, our study also shows that training RNs using SBML to perform USGIV improves patient care. Study Objectives: Current practice at our large, public, urban academic emergency department (ED) is to obtain a screening electrocardiogram (ECG) as part of the medical clearance process on all patients who require transfer to an inpatient psychiatric facility and test positive for cocaine on a urine toxicology screen regardless of the presence or absence of chest pain. The purpose of this retrospective quality improvement study is to examine the utility and impact of a screening ECG for patients with urine toxicology screening positive for cocaine who are chest-pain-free and require medical clearance prior to transfer to an inpatient psychiatric facility.
Methods: An institutional review board-approved, retrospective chart review between January 2014 -December 2015 was performed of all ED patients (1) over 18 years of age, (2) without chest pain documented in the medical record, (3) who required medical clearance in the ED prior to transfer to an inpatient psychiatric facility, (4) who tested positive for cocaine on a screening urine toxicology test, and (5) for whom a screening ECG was obtained. All ECGs were interpreted by an attending physician. Abnormal ECGs were defined as: nonspecific ST changes, T wave inversions, sinus tachycardia, ST elevation, or ST depression. All abnormal ECGs were compared to prior ECGs if available, and if no change noted then these were categorized as normal. Primary outcome was disposition of the patient to an inpatient psychiatric facility versus inpatient medical admission. Secondary outcomes were rates of a subsequent cardiac workup, including inpatient medical admission, cardiac enzymes, stress testing, cardiology consultation, and cardiac catheterization.
Results: During the study period, 1968 ED patients tested positive for cocaine on a urine toxicology screen and 853 met inclusion criteria. ECGs were normal in 809 (95%, 95% CI [93%, 96%]) patients, and abnormal in 44 (5%, 95% CI [4%, 7%]) patients. Of the 44 patients with abnormal ECGs, 4 were admitted for a cardiac workup. Two patients had positive troponins in the ED. Two patients had cardiology consultations and 3 had further cardiac stress testing performed, all of which were negative or nondiagnostic. No cardiac catheterizations were performed on any patients.
Conclusions: Based on the results of our study, the majority of ED patients with recent cocaine use but without chest pain have a normal ECG. Of the minority of patients with an abnormal ECG, there were no cases of acute myocardial ischemia or infarction identified in the absence of chest pain. Therefore, a screening ECG in patients without chest pain simply because of a cocaine-positive urine toxicology test does not appear to identify any cases of myocardial ischemia or infarction and may, in fact, lead to over-testing, increased admission, misuse of resources, and increased cost. Limitations of this study include its retrospective, chart review design. Additionally, there is the possibility of a patient not being forthcoming regarding the presence or absence of chest pain and being categorized incorrectly.
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Checkpoint Inhibitor Complications in the Emergency Department: Methods to Improve Awareness and Outcomes Coyne CJ, Brennan J, Castillo EM, Killeen J, Chan T/University of California San Diego, San Diego, CA; University of California San Diego, San Diego, CA Study Objectives: Immune checkpoint inhibitors (ICPIs) are a novel class of cancer therapeutics that serve to recruit patients' native immune systems to combat cancer. Given initial successes, we have recently seen the release of several new ICPIs, along with expanding ICPI indications. Unfortunately, we have also seen a parallel rise in ICPI-related adverse events presenting to the emergency department. These complications have the potential to escalate into life-threatening autoimmune inflammatory conditions if they are not identified and treated in an expedited fashion. We designed this study to evaluate whether an electronic medical record (EMR)-based ICPI alert tool and educational intervention could improve the outcomes of patients on ICPIs presenting to the emergency department (ED).
Methods: We conducted a retrospective cohort study at 2 academic EDs between April 20, 2015 and April 30, 2018 to evaluate the effectiveness of an EMR-based ICPI educational best practice advisory (BPA) alert. This BPA fired every time the treating provider would initially open the chart of a patient who was receiving an ICPI. The BPA included a link to educational content on the potential side effects of ICPIs. For our study, we evaluated several outcomes based on whether the ED provider utilized the educational content link provided in the BPA (Link+ versus Link-). These outcomes included ED disposition, admission level of care, ED revisits within 7 days, and 30-day hospital readmission rates. Descriptive statistics are reported.
Results: During our study period there were 912 ED visits associated with an ICPI BPA alert. Among these encounters, there were 63 visits when the ED provider accessed the BPA educational link (Link+). There were no significant differences in age, sex, race, or ethnicity among the patient populations. Link+ visits were much more likely to result in an admission than Link-visits (79.4% versus 47.6%), though the admitted patients from the Link-group were more likely to require a higher level of care (ICU or stepdown unit) than the Link+ group (27.4% versus 11%). Among those patients who were discharged, the Link-group was more likely to require a 7-day ED return visit (20.7% versus 16.7%) and was more likely to require a 30-day hospital readmission (23% versus 14%, p<.05). The most common cancers encountered in our cohort were melanoma, lung, breast, and colon.
Conclusions: The results of our study suggest that an EMR-based BPA educational tool has the ability to improve the outcomes of patients on ICPIs. Although we observed a higher initial admission rate for Link+ patients, we also observed lower ED return visits and 30-day readmissions. This may suggest that ICPI complications are being more appropriately diagnosed and treated on the initial visit due to the educational content, leading to improved downstream outcomes. This may also be reflected in the admission level of care difference between the groups. The Link-group was more likely to require a higher level of care, suggesting that the Link+ group may have received more appropriate, aggressive care, targeting the ICPI complications that sometimes mimic other disease processes. As we encounter more ICPIs in the emergency department, an EMR-based educational tool may be helpful in minimizing the potential harms from these novel cancer therapies.
